NCT06167473View on ClinicalTrials.gov

Effect of Different Dosage of Umbilical Cord-mesenchymal Stem Cells Through Peripheral Vein in Patients With ESLD

NAActive, not recruitingINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

November 28, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
End-stage Liver Diseases
Interventions
BIOLOGICAL

umbilical cord-mesenchymal stem cells

Different dosage of umbilical cord-mesenchymal stem cells through peripheral vein

Trial Locations (1)

110840

General Hospital of Northern Theater Command, Shenyang

All Listed Sponsors
lead

General Hospital of Shenyang Military Region

OTHER

NCT06167473 - Effect of Different Dosage of Umbilical Cord-mesenchymal Stem Cells Through Peripheral Vein in Patients With ESLD | Biotech Hunter | Biotech Hunter